Login / Signup
Efficacy of Venetoclax Combined with Decitabine-Based Treatment for Heavily Pre-Treated Relapsed or Refractory AML Patients in a Real-World Setting.
Juan Tong
Na Zhao
Xing Hu
Wen Yao
Yaxin Cheng
Li Zhou
Huilan Liu
Liangquan Geng
Zimin Sun
Changcheng Zheng
Published in:
Cancer management and research (2021)
The efficacy of venetoclax plus decitabine-based treatment in the real-world treatment of heavily pre-treated RR-AML is similar to that in clinical trials, and the side effects are controllable.
Keyphrases
</>
acute myeloid leukemia
clinical trial
newly diagnosed
ejection fraction
randomized controlled trial
acute lymphoblastic leukemia
combination therapy
diffuse large b cell lymphoma
prognostic factors
patient reported outcomes